Search PubMed⌕ Search

Biomedical subjects

F Baud

Publications and source records attributed to F Baud.

61 records · Page 4Linked to original sources

[Complications of Ender's nailing in trochanteric fractures (author's transl)].

A review of complications of 374 fractures of the proximal femoral end, treated by Ender's nailing was conducted: 255 cases only were available because of 46 early deaths and 73 patients without enough follow up. Complications were: 31 superior nails' perforations, 15 downward migrations, 17 dislocations of osteosynthesis and 19 rare complications. The authors believe that Ender's nailing is a great improvement, when compared with classical methods of osteosynthesis or prosthetic replacements. However, a perfect technical execution is necessary to avoid mechanical complications.

Adult↗

[Variations in mucociliary drainage of the nasal fossae after sulfoarsenical thermal therapy].

The saccharine test described by Andersen appears as a simple, harmless and reproducible means to measure the rate of the mucociliary clearance mainly in children. The sweet taste is so strong that the answer is always clear cut. This measured clearance is a good estimate of the efficiency of the first line of defence that builds up the mucus ciliary complex against most of the inhaled noxious agents. In measuring the rate of the clearance in 83 children before and after the Spa treatment (Saint Honoré les Bains), each subject being its own control, the Authors demonstrate a slowing of the clearance speed in 62,1% of the patients, immediately after the end of the Spa period. This percentage is almost reversed 19 days later at the end of the post Spa period. At this time, in 52.2%, an accelerated clearance is measured. This study demonstrates both the efficiency of the Spa treatment, and the necessity, too often overlooked, of 20 days of post Spa medical care.

Arsenamide↗

[Phenotype Pi and alpha 1 antitrypsin deficiency in types A and B chronic obstructive bronchopneumopathies].

The authors studied 79 patients with chronic obstructive lung disease. (COLD) (FEV1/VC less than 70%). Patients with chronic asthma were excluded from the series. These patients with COLD were divided up into 2 groups, depending on radiological and clinical criteria: (1) Type A, primary emphysema, 24 patients; (2) Type B, chronic bronchitis, 49 patients. 6 patients of type X (intermediate type) were excluded. Their respiratory function tests were studied together with clinical and radiological findings and blood gases. Furthermore, were studied in each patient, the antitrypsic activity and the serum concentrations of alpha-1-antitrypsin and phenotype Pi. Group A were, on average, more obstructive than group B. The ratio FEV1/VC was 31% +/- 7% in group A, against 46% +/- 13% in group B. The serum antitrypsin activity and the serum concentration in alpha-1-AT were on average close to normal in both groups. However, group A was divided up into two populations: a small population with a low concentration of alpha-1-AT, and a large population with normal alpha-1-AT. A study of the incidence of various phenotypes in groups A and B showed a significantly higher frequency of phenotype ZZ in group A (12.5%) than in group B (10%). All ZZ subjects were of clinical type A. There was no significant difference in the incidence of other phenotypes encountered. Serum alpha-1-antitrypsin concentration was very low in 3 ZZ patients. One case with phenotype SZ and one MM showed intermediate levels. The authors emphasize the low percentage of cases of pulmonary emphysema which may be explained by an alpha-1-antitrypsin deficiency. Nevertheless, this preliminary report should be completed by a study of a larger sample of patients with COLD with control of the phenotype.

Alleles↗

[The importance of software for the planning and adjusting of dosage. Application with aminoglycosides].

We are presenting a Mac Intosh--Apple computer program (Excel*) for the aminoglycosides (AG) drug monitoring useful in the following situations: --initiation of an AG's dosing regimen depending on the desired peak and through concentration (AG's pharmacokinetic parameters have been calculated according to the AG's literature values). --an adequate dosing regimen after revision of the patient's parameters (calculated with the observed concentrations). The technique has been validated comparing desired (des. C) and measured concentrations (mes. C). --either at the beginning of the treatment, --or after revision of the individual parameters. In the first case, the correlation coefficient obtained between 14 des C and 14 mes. C is equal to 0.91 and is improved when individual parameters are calculated (0.94).

Adolescent↗